Patents by Inventor Callum HICKS

Callum HICKS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11890287
    Abstract: Disclosed herein are compounds, compositions and methods for the treatment of neurological, psychiatric disorders which are characterized by a fundamental disruption of social behaviour, and substance use disorders. In particular, disclosed herein are compounds of Formula (I), or salts or prodrugs thereof. Methods of treating or preventing neurological, psychiatric disorders and substance use disorders, using compounds of Formula (I), or salts and prodrugs are also disclosed.
    Type: Grant
    Filed: May 7, 2021
    Date of Patent: February 6, 2024
    Assignee: Kinoxis Therapeutics Pty Ltd
    Inventors: Iain Stewart McGregor, Michael Kassiou, Michael Thomas Bowen, Callum Hicks, William Jorgensen
  • Publication number: 20220362261
    Abstract: Disclosed herein are compounds, compositions and methods for the treatment of neurological, psychiatric disorders which are characterized by a fundamental disruption of social behaviour, and substance use disorders. In particular, disclosed herein are compounds of Formula (I), or salts or prodrugs thereof. Methods of treating or preventing neurological, psychiatric disorders and substance use disorders, using compounds of Formula (I), or salts and prodrugs are also disclosed.
    Type: Application
    Filed: May 7, 2021
    Publication date: November 17, 2022
    Inventors: Iain Stewart MCGREGOR, Michael KASSIOU, Michael Thomas BOWEN, Callum HICKS, William JORGENSEN
  • Patent number: 11033555
    Abstract: Disclosed herein are compounds, compositions and methods for the treatment of neurological, psychiatric disorders which are characterised by a fundamental disruption of social behaviour, and substance use disorders. In particular, disclosed herein are compounds of Formula (I), or salts or prodrugs thereof. Methods of treating or preventing neurological, psychiatric disorders and substance use disorders, using compounds of Formula (I), or salts and prodrugs are also disclosed.
    Type: Grant
    Filed: July 6, 2016
    Date of Patent: June 15, 2021
    Assignee: Kinoxis Therapeutics Pty Ltd
    Inventors: Iain Stewart McGregor, Michael Kassiou, Michael Thomas Bowen, Callum Hicks, William Jorgensen
  • Publication number: 20190290658
    Abstract: Disclosed herein are compounds, compositions and methods for the treatment of neurological, psychiatric disorders which are characterised by a fundamental disruption of social behaviour, and substance use disorders. In particular, disclosed herein are compounds of Formula (I), or salts or prodrugs thereof. Methods of treating or preventing neurological, psychiatric disorders and substance use disorders, using compounds of Formula (I), or salts and prodrugs are also disclosed.
    Type: Application
    Filed: July 6, 2016
    Publication date: September 26, 2019
    Inventors: Iain Stewart MCGREGOR, Michael KASSIOU, Michael Thomas BOWEN, Callum HICKS, William JORGENSEN